Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children
Author(s) -
Amanda Corbett,
Mina C. Hosseinipour,
Jean Nyirenda,
Cecelia Kanyama,
Naser L. Rezk,
Pax Mkupani,
Dorothy Sichali,
Hsiao Chuan Tien,
Angela D. M. Kashuba,
Charles Mwansambo,
Ralf Weigel,
Peter N. Kazembe
Publication year - 2010
Publication title -
antiviral therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.747
H-Index - 87
eISSN - 2040-2058
pISSN - 1359-6535
DOI - 10.3851/imp1488
Subject(s) - pharmacokinetics , stavudine , nevirapine , lamivudine , dosing , medicine , crossover study , gastroenterology , pharmacology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , virology , hepatitis b virus , virus , alternative medicine , pathology , placebo
The aim of this study was to evaluate the pharmacokinetics of lamivudine (3TC), stavudine (d4T) and nevirapine (NVP) in HIV-infected Malawian children receiving quartered tablet multiples of Triomune 40 (generic tablet [GT]) compared with individual generic liquid (GL) and trade liquid (TL).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom